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ABSTRACT 
Introduction 
Many recent studies concerning autologous fat grafting in the eyelids have been published, 
mostly consisting of case reports and retrospective case series. However, no study on the 
overall complication or satisfaction rate associated with the various grafting techniques exists. 
We performed a comprehensive literature review to determine the outcomes and 
complications of eyelid fat grafting, as well as patient satisfaction. 
Methods:  
A systematic review of the literature using the PRISMA criteria was conducted. This protocol 
was registered at the Prospective Register of Systematic Reviews at the National Institute for 
Health Research. 
Results: 
Sixteen studies, representing 1,159 patients and published between June 2004 and December 
2014, were included. Satisfactory results, judged by clinical examination, were observed in all 
studies. Few postoperative complications were reported.   
Conclusions: 
We demonstrated that the procedures were easy to perform, and achieved satisfactory and 
sustainable results with few complications in both reconstructive and cosmetic surgery. 
However, a wide disparity exists in the various fat harvesting, fat purification, and reinjection 
techniques. Further studies are required to assess the long-term outcomes. Our conclusions 
should be accepted cautiously due to the small number of articles and the lack of evidence in 
published studies. 
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INTRODUCTION 
The loss of facial volume, especially in the periorbital region, is an important component 
of aging and is due to the redistribution and atrophy of facial fat (Gossain et al., 2005; Le 
Louarn, 2009; Rohrich et al., 2009; Rohrich & Pessa, 2007). Traditional approaches to 
facial rejuvenation have relied on subtractive surgical techniques, focusing on the 
excision of skin, muscle, and/or fat (Massry & Azizzadeh, 2005). Modern approaches 
concentrate instead on filling the “empty” facial compartments, mainly through fat 
grafting (Serra-Renom & Sera-Mestre, 2011). 
Autologous fat grafting is a technique that has been increasingly used in plastic surgery 
over the last decade. Initially described by Coleman (Coleman, 1995), fat grafting is used 
as an adjuvant treatment to blepharoplasty, and can be performed at either the beginning 
or end of the procedure (Tonnard et al., 2013; Trepsat, 2003). The technique aids facial 
rejuvenation by increasing the volume in atrophied areas (Trepsat, 2003). Furthermore, it 
allows for the regeneration of treated areas due to the presence of adipose-derived stem 
cells (ASCs) via the synthesis of trophic and immunomodulatory factors (Bertheuil et al., 
2015). Because of this, fat grafting has practical applications in both reconstructive and 
cosmetic surgery. 
The objective of this review was to define the indications for eyelid fat grafting, outline 
the available techniques, assess the results, operative morbidity, and patient satisfaction, 
and clarify its role in popularizing facial rejuvenation. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
MATERIALS AND METHODS 
Study design 
We conducted a systematic literature review to assess the level of interest in the eyelid fat 
grafting procedure, outline the available techniques, and assess complications and patient 
satisfaction. 
This review was undertaken in accordance with the PRISMA (Preferred Reporting Items 
for Systematic Reviews and Meta-analysis) criteria. This protocol, which follows the 
AMSTAR (A Measurement Tool to Assess Systematic Reviews) criteria, was registered 
at the Prospective Register of Systematic Reviews at the National Institute of Health 
Research (NIHR), and is available online: 
(http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015015759). 
We interrogated the MEDLINE database via PubMed and the Cochrane Library in 
December 2014 using the following keywords: ["fat grafting" OR "fat transplantation" 
OR "fat injection" OR "lipofilling" OR "lipotransfer" OR "lipomodeling" OR "adipose 
derived stem cell" AND "eyelid" OR "periocular"]. The references of collected articles 
were also examined to identify relevant articles. 
The titles, abstracts, and full text of the retrieved articles were examined by two 
reviewers (EB and NB), and disagreements were resolved by consensus. Where it was not 
possible to reach consensus, one of the senior authors was required to make the final 
decision (BC). 
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Selection criteria 
Original articles published between June 2004 and December 2014, related to patients 
who had received eyelid(s) fat grafting, were included in this review. These articles 
included prospective controlled clinical trials, prospective or retrospective observational 
studies, and clinical cases. Excluded articles included those written in languages other 
than English or French, those that involved animal testing, letters to editors, duplicates, 
and those reporting data from other studies without including original data of their own. 
Data collection 
Two independent reviewers undertook a detailed and critical reading of each complete 
article to obtain the following data: authors, publication date, place of study, article type 
and evidence level, number of patients, indications, surgical technique, complications, 
and the therapeutic possibilities suggested by the authors. The data were organized into a 
table using Microsoft Excel® 2011 (Microsoft Corp., Redmond, WA, USA). For each 
article, a level of evidence, as defined by the Oxford Centre for Evidence-Based 
Medicine (EBM), was awarded (Table 1). 
RESULTS 
Among the 218 articles initially identified by our search, 16 were finally selected (Fig. 1) 
and these included 1,159 patients (Fig. 2). Most of the articles were published after 2010 
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(Fig. 3), had a low level of evidence (Table 1), and were principally North American, 
European, and Asian publications (Tables 1 and 2). 
Indications 
Eyelid fat grafting had indications in aesthetic and reconstructive surgery. Aesthetically, 
the main surgical indications were the correction of dark circles (Roh et al., 2009), as an 
adjuvant to blepharoplasty, or as an alternative treatment for hollow eyes and malar bags 
(Tonnard et al., 2013). Photographs of patients at a younger age were occasionally needed 
to better assess age-related volume loss (Tonnard et al., 2013; Ciuci & Obagi, 2008). 
In reconstructive surgery, fat grafting could be employed after eyelid trauma, post-
treatment for eyelid tumors (post-surgery or post-radiotherapy), in congenital 
malformations, dysmorphic syndromes affecting the eyelids (Parry-Romberg syndrome 
(Clauser et al., 2010; Clauser et al., 2011), Treacher Collins syndrome (Clauser et al., 
2011)), burns, scars, eyelid sequelae of facial paralysis, scleroderma, and sequelae of 
chronic radiodermatitis (Clauser et al., 2011). A case of ectropion secondary to a burn 
scar treated by fat grafting was also described with good results in terms of ocular 
symptoms (Caviggioli et al., 2008). 
Preoperative preparation 
None of the authors recommended a particular preoperative ophthalmologic assessment 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
or any complementary tests. The procedure was performed under either general 
anesthesia (Tonnard et al., 2013; Clauser et al., 2010; Clauser et al., 2011; Lee et al., 
2011; Duhoux et al., 2013; Lin et al., 2014) or local anesthesia (Serra-Renom & Serra-
Mestre, 2011; Clauser et al., 2011; Caviggioli et al., 2008; Lin et al., 2014; Le et al., 
2014) with lidocaine 2% and diluted adrenaline 1/200,000 (Serra-Renom & Serra-Mestre, 
2011) to 1/1,000,000 (Tonnard et al., 2013). Tonnard was of the opinion that another type 
of eyelid surgery (e.g., blepharoplasty) could be performed simultaneously (Tonnard et 
al., 2013). 
Fat-harvesting 
Fat was harvested from the abdomen (Serra-Renom & Serra-Mestre, 2011; Tonnard et al., 
2013; Roh et al., 2009; Clauser et al., 2010; Clauser et al., 2011; Caviggioli et al., 2008; 
Lee et al., 2011; Duhoux et al., 2013; Lin et al., 2014; Thaunat et al., 2004; Tonnard et al., 
2013; Einan-Lifshitz et al., 2013), hips (Tonnard et al., 2013), trochanteric regions 
(Clauser et al., 2011), thighs (Tonnard et al., 2013; Clauser et al., 2011; Le et al., 2014; 
Einan-Lifshitz et al., 2013), and/or medial aspect of the knees (Clauser et al., 2011; Le et 
al., 2014), with a preference for the infra-umbilical fat (Serra-Renom & Serra-Mestre, 
2011; Clauser et al., 2010; Caviggioli et al., 2008; Lee et al., 2011; Duhoux et al., 2013; 
Lin et al., 2014; Thaunat et al., 2004; Tonnard et al., 2013). Roh et al. also harvested fat 
from the buttocks (Roh et al., 2009). The choice of donor site did not appear to affect the 
end result. 
The technique employed by Coleman (Lin et al., 2014) was used by most authors to 
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harvest fat. Fat was removed by applying a manual negative pressure, with the aid of a 3-
mm blunt tip cannula (Serra-Renom & Serra-Mestre, 2011; Tonnard et al., 2013; Clauser 
et al., 2011; Tonnard et al., 2013) – 14-gauge (Roh et al., 2009; Le et al., 2014) or 18-
gauge (Youn et al., 2013) – attached to a 10-cc LuerLock® syringe (Serra-Renom & 
Serra-Mestre, 2011; Tonnard et al., 2013; Roh et al., 2009; Clauser et al., 2011; Lin et al., 
2014; Tonnard et al., 2013; Einan-Lifshitz et al., 2013; Youn et al., 2013) with 1 mm 
holes (Tonnard et al., 2013). Harvesting needed to be symmetrical, regular, and 
sufficiently deep under the superficial fascia to leave no sequelae at the donor site. Some 
authors stated that they applied a gentle negative pressure with the plunger pulled no 
more than 2 mL at a time to prevent an impact from excessive negative pressure on the 
survival of adipocytes (Clauser et al., 2011; Einan-Lifshitz et al., 2013; Youn et al., 
2013). 
Treatment of fat (fat-processing/purification) 
Most authors used centrifugation (Serra-Renom & Serra-Mestre, 2011; Clauser et al., 
2010; Clauser et al., 2011; Caviggioli et al, 2008; Duhoux et al., 2013; Lin et al., 2014; 
Thaunat et al., 2004) at 3,000 rpm for 3 minutes (Serra-Renom & Serra-Mestre, 2011; 
Clauser et al., 2010; Clauser et al., 2011; Caviggioli et al., 2008; Lin et al., 2014) to 
process the fat, after which three levels were observed in the syringe. The lower level 
corresponded to hematopoietic and endothelial cells as well as local anesthetics. The 
upper level was oily and contained the adipocytes destroyed during collection and 
centrifugation (Serra-Renom & Serra-Mestre, 2011; Clauser et al., 2011). This level was 
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eliminated because it can decrease the grafted fat take and cause oil cysts to form. Only 
the intermediate level was used for reinjection. In addition, some authors preferred to use 
a nylon filter (Tonnard et al., 2013; Tonnard et al., 2013), a sheet of paper (Roh et al., 
2009), a Telfa dressing pad (Einan-Lifshitz et al., 2013), or even a steel sieve (Le et al., 
2014) to filter the fat, without any sufficient level of evidence demonstrating the 
superiority of a particular purification technique.
Reinjection of fat 
Fat reinjection was an important step in the overall success of the graft. The fat lobules 
needed to be distributed in the least traumatic way possible, within a nurturing 
environment, to survive. The reinjection site could be infiltrated with lidocaine 0.3% 
and/or diluted adrenaline at 1/600,000 in the case of general anesthesia, and with 
lidocaine 1% and epinephrine 1/200,000 in the case of local anesthesia (Tonnard et al., 
2013). 
The reinjection of the fat was performed with a 17-gauge (Serra-Renom & Serra-Mestre, 
2011), 18-gauge (Roh et al., 2009; Caviggioli et al., 2008; Lin et al., 2014), 16 to 19-
gauge (Le et al., 2014), 19-gauge (Einan-Lifshitz et al., 2013), 19 to 21-gauge (Tonnard et 
al., 2013), or even a 22-gauge (Youn et al., 2013) cannula in the case of treatment by 
"collagenase fat-grafting", while a 27-gauge cannula was used for "nanofat-grafting" 
(Tonnard et al., 2013). The cannula was connected to a 10-mL (Duhoux et al., 2013) or 1-
mL LuerLock® syringe (Serra-Renom & Serra-Mestre, 2011; Tonnard et al, 2013; Roh et 
al., 2009; Clauser et al., 2011; Lin et al., 2014; Le et al., 2014; Einan-Lifshitz et al., 2013; 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Youn et al., 2013). Traditional fat-grafting techniques have evolved toward microfilling 
with the use of increasingly small cannulas. 
Fat was injected in longitudinal tunnels that formed a three dimensional (3D) mesh to 
promote revascularization and graft survival, per Coleman’s technique (Serra-Renom & 
Serra-Mestre, 2011). 
In the upper eyelids, fat grafting was generally used to fill hollow eyelids. The injections 
were sometimes carried out in conjunction with blepharoplasty (Lin et al., 2014). The 
injection sites were located at the medial 2/3 of the upper eyelid, the infero-medial 1/3 of 
the eyebrow, and the lateral part of the eyebrow (Tonnard et al., 2013). The injected 
volume ranged between 0.5–2.5 cc, as judged necessary to fill the volume loss (Tonnard 
et al., 2013). Some authors advocated blepharoplasty after fat grafting due to anatomical 
changes induced by the latter (Trepsat, 2003). 
In the lower eyelids, fat grafting helped to restore volume, including that of the 
periorbital region. The injection points were located external to the zygomatic bone 
(Tonnard et al., 2013; Le et al., 2014) and at “the valley of tears” (Le et al., 2014). 
Injections were avoided in-between the skin and muscle in this area, due to the thinness 
of the skin, which may lead to palpable irregularities (Serra-Renom & Serra-Mestre, 
2011). The injected quantities ranged from 0.5 to 10 cc (Tonnard et al., 2013; Roh et al., 
2009; Caviggioli et al., 2008; Le and al., 2014) according to the degree of volume loss 
(Tonnard et al., 2013). Some authors performed fat grafting after blepharoplasty (Einan-
Lifshitz et al., 2013). Bilateral injections using fat collected from one area were suggested 
to avoid postoperative asymmetry, since the fat quality may vary according to the 
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collection site (Duhoux et al., 2013). 
Patient Satisfaction 
Only four studies (25%) assessed the patients’ satisfaction, and all of them reported a 
high rate of between 78% and 100% (Serra-Renom & Serra-Mestre, 2011; Roh et al., 
2009; Lin et al., 2014; Youn et al., 2013). 
Lin et al. noted that 167 of 168 patients were satisfied, with no explanation of the method 
of evaluation (Lin et al., 2014). Serra-Renom employed two non-validated scales at 24 
months, one completed by the patients and the other by an independent medical team, 
using an ascending scale ranging from 1 to 4 (poor, fair, good, and excellent) (Serra-
Renom & Serra-Mestre, 2011). The mean score awarded by the patients was 3.91 
(93.79% of patients reported excellent results) versus 3.97 awarded by the medical team 
(97.67% excellent results). Roh et al. (2009) evaluated their results using a similar 
questionnaire by an independent medical team at 3 months post-operation. The average 
score of their 10 patients was 2.6. Youn et al. (2013) evaluated their results for correction 
of dark circles using the Fitzpatrick scale, a recognized tool for dermatological research 
into skin pigmentation (grades 1–6). Patients were divided into three groups (worse, no 
change, improved), and the final results indicated that 67.1% of the patients had 
improved, 28% remained unchanged, and 4.9% were worse. 
Complications 
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The majority of the reported complications were minor (Tonnard et al., 2013; Einan-
Lifshitz et al, 2013). The main “complication” was the resorption of fat (Lin et al., 2014; 
Einan-Lifshitz et al., 2013), evidenced by clinical examination (Trepsat et al., 2003; 
Clauser et al., 2011), for which the authors used supplementary injections of fat or 
synthetic products (Einan-Lifshitz et al., 2013). None of the studies used any tests to 
determine the rate of resorption. 
Other complications included bruising and swelling persisting beyond 15 days (Lin et al., 
2014), which could be reduced by applying ice, asymmetry (Serra-Renom & Serra-
Mestre, 2011), migration of fat (Serra-Renom & Serra-Mestre, 2011), calcifications, and 
paresthesia. Fat hypertrophy was identified by Tonnard et al. (2013), in one patient out of 
500, and by Duhoux et al. (2013), and occurred after postoperative weight changes. 
Correction of fat hypertrophy could take place by liposuction under local anesthesia 
(Tonnard et al., 2013) or by direct excision (Duhoux et al., 2013). Lipogranuloma (Le et 
al., 2014) could be treated by surgical excision, or by a local or systemic steroid injection 
(Le et al., 2014; Sa et al., 2011). Granulomas could be found in periorbital areas, away 
from the injection site, e.g., after a forehead fat injection (Sa et al., 2011). 
Over-corrections and irregularities (Roh et al., 2009) could be treated with massage, 
excision, liposuction, and/or corticosteroid injections in the grafted fat to allow it to 
atrophy (Le et al., 2014; Sa et al., 2011). 
More serious complications, such as central retinal artery occlusion (Lee et al., 2011; 
Chen et al., 2014) and multiple cerebral infarctions (Lee et al., 2011; Thaunat et al., 2004) 
– sometimes concomitantly (Lee et al., 2011) – were reported, mainly in the case of 
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injection into the glabella and forehead, and rarely during the treatment of the upper 
eyelids (Lee et al., 2011; Chen et al., 2014). These occlusions left major sequelae, 
particularly when the occlusion was complete (Chen et al., 2014; Park et al., 2012). A 
patient who had received an eye massage, treatment by intravenous mannitol, and oxygen 
therapy experienced no visual improvement (Lee et al., 2011). These complications 
appeared to be secondary to fat embolism (Thaunat et al., 2004). A case of severe 
diplopia was described after fat hypertrophy in a patient who gained 15 kg within 2 years 
of fat grafting. Magnetic resonance imaging (MRI) identified a mass of subcutaneous fat 
reaching the orbital floor through an inferior septal defect. After excision of the mass, the 
symptoms disappeared completely (Duhoux et al., 2013). 
New perspectives - mesenchymal stem cell therapy from adipose tissue 
The use of fat grafting has undergone exponential growth since its popularization by 
Coleman. While initially used to reverse volume loss caused by different etiologies, this 
technique has also expanded into regenerative and reparative medicine due to the 
discovery of mesenchymal stem cells (MSCs) within the adipose tissue (Zuk et al., 2001), 
termed adipose-derived stem cells (ASCs). These cells are particularly advantageous for 
tissue regeneration; they act by supporting neoangiogenesis as well as through the 
reduction of inflammation and tissue fibrosis (Bertheuil et al., 2015). This explains the 
rapid development in regenerative medicine in recent years due to the invention of 
techniques – in contrast to fat grafting – that rely on the transfer of the stromal vascular 
fraction containing these cells (Tonnard et al., 2013; Youn et al., 2013). Injection of 
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stromal cells into tissue already treated by standard fat grafting techniques has led to 
improvements in graft survival, mainly by enhancing angiogenesis (Kolle et al., 2013). 
Two of the studies in our review used this concept. The first study reported treatment of 
91 patients for dark circles with the enzymatic digestion of adipose tissue that had been 
centrifuged using Coleman’s technique. The intermediate level was digested by 
collagenase type 2 derived from Clostridium histolyticum (Sigma-Aldrich, St. Louis, 
USA) for 25 minutes at 37°C, after which the product was washed, centrifuged, and then 
injected into the patients. The authors reported a clinical improvement at 3 months by 
comparing pre- and postoperative photographs taken by three different doctors and rating 
the results as either improved, unchanged, or worse. According to this classification 
system, 67.1% of patients had improved, 28% remained unchanged, and 4.9% were 
found to be worse. In this study, the reinjected product corresponded to the stromal 
vascular fraction. However, no real characterization of the product was undertaken. 
The second study (Tonnard et al., 2013) concerned 67 patients who were treated for 
superficial rhytides, scars, and dark circles by “nanofat grafting”. The fat was 
mechanically treated by passing it 30 times from one 10-cc syringe into another, allowing 
fragmentation and the formation of an emulsion. The authors attempted to characterize 
the product by demonstrating the absence of surviving adipocytes and the probable 
presence of MSCs. However, they did not provide sufficient evidence to indicate that 
these were actually ASCs. No adverse effects were observed, and the quality of the 
treated skin at 6 months post-operation was found to be significantly improved, which 
was very promising. 
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DISCUSSION 
The transfer of adipose tissue was described for the first time in the late 19th century. A 
century later, following its popularization by Coleman, this technique has gained a 
prominent place within plastic, reconstructive, and aesthetic surgery. The objectives of fat 
grafting have since doubled; the primary goal was the reversal of a loss of substance; 
however, in the last decade it has been increasingly used for tissue regeneration. These 
use of these techniques is increasing exponentially in regenerative surgery due to the 
presence of MSCs that, through the synthesis of trophic and immunomodulatory factors, 
promote neoangiogenesis and decrease inflammation and local tissue fibrosis. A greater 
understanding of facial aging mechanisms – consisting of fat atrophy and ptosis of the 
different facial compartments – has allowed fat grafting to be considered as a possible 
technique for facial rejuvenation, particularly of the eyelids. 
Our literature review included more than 1,159 patients worldwide, and thus provides an 
overview of current international practice. It is interesting to note that, at present, the 
literature includes only retrospective studies and clinical cases, and therefore the level of 
evidence regarding this subject is still weak (3 to 5 EBM). The main indication for 
eyelid-lipofilling was aesthetic concerns (1,096 patients) such as dark circles (159 
patients, 14.5% of aesthetic surgery). Another major indication was reconstruction by 
filling-in substance loss regardless of the cause. 
Currently, there is no evidence in the literature to support a specific standardization of the 
procedure (Gir et al., 2012). The main innovations included the development of 
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associated technologies to improve graft survival, such as stem cell enrichment. These 
methods are encouraging (Arononowitz & Ellenhorn, 2013); however, their broad 
application is difficult given the cost and ethical constraints (Kolle et al., 2013). 
The cosmetic results of the procedure appeared to be satisfactory according to most of the 
authors. Nevertheless, an objective assessment tool of the end result was lacking . 
Contrary to breast fat grafting, no study had evaluated the rate of resorption of the grafted 
fat in the eyelids. This type of research – whether by MRI (Gosain et al., 2005) or by 
other methods (Guibert et al., 2013) –  is required to analyze the retention rate and overall 
rejuvenation of the eyelids. 
This paper demonstrates that postoperative complications arising from the fat grafting 
procedure were few and were usually minor. The major complication we identified was 
cerebral or ocular artery thrombosis, but that was exceptional and mainly occurred in the 
case of injections in dangerous areas such as the glabella and nasolabial folds (Park et al., 
2008). It was almost always linked to an increase in local pressure resulting in a reflux of 
the fat into the ophthalmic artery and the internal carotid artery (Park et al., 2008). To 
limit this risk (which can be made worse by vascular injury), and the risks of fat 
embolism and serious consequences, verification of an absence of blood reflux into the 
syringe prior to injection, slow injection at low pressure, and the use of a blunt-tip 
cannula, were recommended (Park et al., 2008). 
Fat hypertrophy was reported (n = 2/1,159) after significant weight gain following the 
intervention. Patients should therefore be warned before the operation that a stable 
postoperative weight is required. 
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The current area of research interest concerns the development of microfat grafting 
techniques in addition to injection of the stromal vascular fraction (SVF) into adipose 
tissue, which is of particular interest for facial rejuvenation treatments including those for 
dark circles. Several techniques are being developed to extract fractions containing ASC, 
their methods being either enzymatic (Youn et al., 2013) or mechanical (Tonnard et al., 
2013; Raposio et al., 2014). Indeed, these authors demonstrated the possibility of an SVF 
graft without the digestion of the tissues by proteolytic enzymes and, more importantly, 
without expensive specialized devices (Aronowitz & Ellenhorn, 2013). However, none of 
these studies characterized the product they reinjected for assessment of the presence of 
viable ASCs and their proportions. In addition, none had demonstrated the stemness 
(Dominici et al., 2006) of the injected SVF cells. These cells were defined in vitro by 
several criteria (Bertheuil & Chaput, 2015). 
This study had several limitations. First, there was a language bias because our inclusion 
criteria only allowed for selection of articles in English or French. Second, despite the 
fact that the fat grafting procedure is now fully developed, our study showed that the 
level of evidence within published series remains insufficient. None of the articles 
included in our study adequately measured their results; for example, there was a lack of 
evaluation of the fat retention rates, long-term outcome of the patients, or satisfaction 
rate; there was also no assessment of quality of life after surgery using validated 
instruments. Therefore, we were unable to reach firm conclusions regarding all of these 
points. It is essential to continue the ongoing work to fully characterize the products 
reinjected into patients, so that their mechanisms of action can be clarified and also to 
ensure fewer random results. 
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Further studies are required to optimize the collection, processing, and reinjection of fat, 
especially with respect to those techniques that are not strictly concerned with fat grafting 
but rather with SVF grafting. These techniques – whether they are associated with 
traditional fat grafting or not – provide encouraging results and suggest that graft survival 
could be improved. Furthermore, patients in some studies appeared to have a lower 
associated morbidity than for conventional fat grafting. 
CONCLUSION 
Most facial volume loss is due to fat atrophy, for which autologous fat grafting is the 
ideal form of tissue replacement. Fat grafting is therefore a possible technique for 
reshaping the eyelids and correcting their flaws. 
This literature review revealed that fat grafting procedures were easy to perform, and 
achieved satisfactory and sustainable results with few complications in both 
reconstructive and cosmetic surgery. 
Eyelid fat grafting appears to be a promising tool, but we have highlighted the existence 
of a wide disparity in the fat harvesting, fat purification, and reinjection techniques. 
Moreover, further studies are required to assess long term outcomes, such as the fat 
retention rate, which have not been addressed in the studies included in this review. 
Likewise, new modalities such as stromal vascular fraction grafting are in development, 
and these will open new doors in regenerative and reconstructive surgery. 
However, our work has shown that any conclusions must be made cautiously due to the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
small number of articles available and the lack of evidence in the published studies. 
The English in this document has been checked by at least two professional editors, both 
native speakers of English. For a certificate, please see:   
http://www.textcheck.com/certificate/5zevvS 
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Table 1 - Presentation of publications, country and level of Evidence Based Medicine. 
        
Article Country Study design Evidence level 
Thaunat O, 2004 France Case report  5 
Caviggioli F, 2008 Italy Retrospective cohort 3 
Roh MR, 2009 South Korea Retrospective cohort 3 
Clauser LC, 2010 Italy Case report  5 
Lee C, 2011 South Korea Case report  5 
Sa HS, 2011  South Korea Case series 4 
Clauser LC, 2011 Italy     Retrospective cohort 3 
Serra Renom J, 2011 Spain Retrospective cohort 3 
Duhoux A, 2013 France Case report  5 
Youn S, 2013 South Korea Retrospective cohort 3 
Tonnard P, 2013 Belgium Retrospective cohort 3 
Tonnard P, 2013 Belgium Retrospective cohort 3 
Einan Lifshitz A, 2013 USA Retrospective cohort 3 
Chen Y, 2014  China Case series 4 
Lin TM, 2014 China Retrospective cohort 3 
Le TP, 2014  USA Retrospective cohort 3 
        
?
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 2 – Geographical distribution of publications and patients. 
      
Country of origin Number of articles  Number of patients 
South Korea 4 102 
Italy 3 49 
Belgium 2 567 
China 2 175 
France 2 2 
USA 2 127 
Spain 1 142 
      
MA
NU
SC
RIP
T
 
AC
CE
PT
ED
A
C
C
EP
TE
D
 M
A
N
U
SC
R
IP
T
? T
ab
le
 3
 - 
D
et
ai
ls
 o
n 
fa
t g
ra
fti
ng
 te
ch
ni
qu
e 
  
  
  
  
  
  
  
  
A
rt
ic
le
 
an
es
th
es
ia
 
D
on
or
 si
te
 
Fa
t H
ar
ve
st
in
g 
Fa
t P
ro
ce
ss
in
g 
In
je
ct
io
n 
In
je
ct
io
n 
Si
te
 
In
je
ct
ed
 V
ol
um
e 
(m
L)
 
Th
au
na
t O
, 2
00
4 
N
R
 
A
bd
om
en
 
N
R
 
C
en
tri
fu
ga
tio
n 
  
N
R
 
Lo
w
er
 a
nd
 U
pp
er
 
ey
el
id
 
N
R
 
C
av
ig
gi
ol
i F
, 2
00
8 
Lo
ca
l  
A
bd
om
en
 
N
R
 
C
en
tri
fu
ga
tio
n 
  
18
 g
au
ge
s c
an
nu
la
 
Lo
w
er
 e
ye
lid
 
0,
5 
cc
 
R
oh
 M
R
, 2
00
9 
N
R
 
A
bd
om
en
, G
lu
te
al
 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
, 1
4 
G
au
ge
s c
an
nu
la
  
fil
tra
tio
n 
1 
cc
 sy
rin
gu
e,
 1
8 
ga
ug
es
 c
an
nu
la
 
Lo
w
er
 e
ye
lid
 
1 
- 2
cc
 
C
la
us
er
 L
C
, 2
01
0 
G
en
er
al
 
A
bd
om
en
 
10
 c
c 
sy
rin
gu
e 
  
C
en
tri
fu
ga
tio
n 
  
N
R
 
Lo
w
er
 a
nd
 U
pp
er
 
ey
el
id
 
N
R
 
Le
e 
C
, 2
01
1 
G
en
er
al
 
A
bd
om
en
 
N
R
 
N
R
 
N
R
 
N
R
 
N
R
 
Sa
 H
S,
 2
01
1 
 
N
R
 
N
R
 
N
R
 
N
R
 
N
R
 
Lo
w
er
 e
ye
lid
 
N
R
 
C
la
us
er
 L
C
, 2
01
1 
G
en
er
al
 o
r 
Lo
ca
l 
A
bd
om
en
, H
ip
s, 
M
ed
ia
l T
hi
gh
 a
nd
 
K
ne
e 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
, 3
 
m
m
 c
an
nu
la
 
C
en
tri
fu
ga
tio
n 
  
1 
cc
 sy
rin
gu
e 
N
R
 
N
R
 
Se
rr
a 
R
en
om
 J,
 2
01
1 
Lo
ca
l 
A
bd
om
en
 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
, 3
 
m
m
 C
ol
em
an
's 
ca
nn
ul
a 
C
en
tri
fu
ga
tio
n 
1 
cc
 sy
rin
gu
e,
 1
7 
ga
ug
es
 c
an
nu
la
 
N
R
 
N
R
 
D
uh
ou
x 
A
, 2
01
3 
G
en
er
al
 
A
bd
om
en
 
N
R
 
C
en
tri
fu
ga
tio
n 
10
 c
c 
sy
rin
gu
e 
Lo
w
er
 e
ye
lid
 
N
R
 
Y
ou
n 
S,
 2
01
3 
N
R
 
N
R
 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
, 1
8 
G
au
ge
s c
an
nu
la
  
C
en
tri
fu
ga
tio
n,
 C
ol
la
ge
na
se
 
Pr
oc
es
si
ng
, W
as
hi
ng
 a
nd
 
C
en
tri
fu
ga
tio
n 
1 
cc
 sy
rin
gu
e,
 2
2 
ga
ug
es
 c
an
nu
la
 
N
R
 
N
R
 
To
nn
ar
d 
P,
 2
01
3 
G
en
er
al
 o
r 
Lo
ca
l 
A
bd
om
en
, H
ip
s, 
M
ed
ia
l T
hi
gh
 a
nd
 
K
ne
e 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
, 2
-3
 
m
m
 c
an
nu
la
 w
ith
 1
m
m
 h
ol
e 
fil
tra
tio
n 
1 
cc
 sy
rin
gu
e,
 1
9 
to
 
21
 g
au
ge
s c
an
nu
la
 
Lo
w
er
 a
nd
 U
pp
er
 
ey
el
id
 
0,
5 
- 2
,5
 c
c 
(U
pp
er
), 
4-
10
cc
 (L
ow
er
) 
To
nn
ar
d 
P,
 2
01
3 
N
R
 
A
bd
om
en
 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
, 3
 
m
m
 c
an
nu
la
 w
ith
 1
m
m
 h
ol
es
 
fil
tra
tio
n 
27
 g
au
ge
s c
an
nu
la
 
N
R
 
N
R
 
Ei
na
n 
Li
fs
hi
tz
 A
, 
20
13
 
N
R
 
A
bd
om
en
, M
ed
ia
l 
Th
ig
h 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
 
 fi
ltr
at
io
n 
th
ro
ug
h 
a 
te
lfa
 p
ad
 
1 
cc
 sy
rin
gu
e,
 1
9 
ga
ug
es
 c
an
nu
la
 
Lo
w
er
 e
ye
lid
 
N
R
 
C
he
n 
Y
, 2
01
4 
 
N
R
 
N
R
 
N
R
 
N
R
 
N
R
 
Lo
w
er
 a
nd
 U
pp
er
 
ey
el
id
 
N
R
 
MA
NU
SC
RIP
T
 
AC
CE
PT
ED
A
C
C
EP
TE
D
 M
A
N
U
SC
R
IP
T
Li
n 
TM
, 2
01
4 
G
en
er
al
 o
r 
Lo
ca
l 
A
bd
om
en
 
10
 c
c 
sy
rin
gu
e 
lu
er
 lo
ck
 
C
en
tri
fu
ga
tio
n 
  
1 
cc
 sy
rin
gu
e,
 1
8 
ga
ug
es
 c
an
nu
la
 
Lo
w
er
 e
ye
lid
 
N
R
 
Le
 T
P,
 2
01
4 
 
Lo
ca
l 
M
ed
ia
l T
hi
gh
 a
nd
 
K
ne
e 
14
 G
au
ge
s c
an
nu
la
  
W
as
hi
ng
 th
ro
ug
h 
m
es
h 
st
ra
in
er
 
1 
cc
 sy
rin
gu
e,
 1
6 
to
 
19
 g
au
ge
s c
an
nu
la
 
Lo
w
er
 e
ye
lid
 
0 
- 2
cc
  
  
  
  
  
  
  
  
  
N
R
: N
ot
 re
po
rte
d 
In
je
ct
ed
 fa
t v
ol
um
e:
 a
re
 e
xp
re
ss
ed
 b
y 
m
ea
n 
in
 b
ot
h 
si
de
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 4 - Indications and complications 
  ?? ?? ??
Article Number of 
patients Indications complications 
Thaunat O, 2004 1 Reconstruction cerebral infarction 
Caviggioli F, 2008 1 Reconstruction NR 
Roh MR, 2009 10 Aesthetic (dark eyelid) No 
Clauser LC, 2010 1 Reconstruction NR 
Lee C, 2011 
1 NR 
ophthalmic artery 
occlusion, cerebral 
infarction 
Sa HS, 2011  9 NR Granuloma (n=1) 
Clauser LC, 2011 47 Reconstruction No 
Serra Renom J, 2011 142 Aesthetic  fat asymmetry (n=1) 
Duhoux A, 2013 1 Reconstruction fat growth, diplopia 
Youn S, 2013 82 Aesthetic (dark eyelid) No 
Tonnard P, 2013 
500 Aesthetic  
fat growth (n=1), scleral 
show (n=5) 
Tonnard P, 2013 67 
Aesthetic (skin 
rejuvenation) No 
Einan Lifshitz A, 
2013 57 Aesthetic 
under correction with 
reoperation (n=2) 
Chen Y, 2014  
2 NR 
ophthalmic artery occlusion 
(n=2) 
Lin TM, 2014 
168 Aesthetic (sunken eyelid) 
under correction with 
reoperation (n=1) 
Le TP, 2014  70 Aesthetic No 
        
NR: Not reported 
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